BioNTech is a biotechnology company based in Mainz, Germany that trades on Nasdaq. BioNTech develops and manufactures modern patient-specific immunotherapies for different diseases, including the Pfizer-BioNTech Covid-19 vaccine. Learn the latest information and analysis on the company, BNTX stock price today, stock news, how much one share costs and other information to help you make investment decisions.
Check out Gainy to see insights on stock prices and more.
Even though many think the Covid pandemic is over and many of the restrictions have been lifted in countries around the world, BioNTech and its partner Pfizer signed orders for 2.4 billion Covid vaccines for 2022. We are likely to see more orders by the end of this year.
The BioNTech stock price fell by 60% in 6 months from November, 2021, which makes the current stock price of $140 a great entry point for those who expect Covid to come back. In any case, the partnership with Pfizer will give the $33 billion company a boost whatever happens.
Check back to this page for the BNTX stock quote or download Gainy to see if BNTX fits your portfolio and investment goals, get other stock quotes and recommendations that fit your portfolio and interests.